2011
DOI: 10.1039/c1cc13341a
|View full text |Cite
|
Sign up to set email alerts
|

A phosphoarginine containing peptide as an artificial SH2 ligand

Abstract: We have developed a synthesis of phosphoarginine containing peptides using a bis(2,2,2-trichloroethyl) protected phosphoarginine derivative as building block. Binding studies and computer modelling demonstrate the ability of the SH2 domain from Src kinase to recognize a phosphoarginine-containing peptide in a phosphoryl group-dependent manner.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
24
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 30 publications
(32 reference statements)
0
24
0
Order By: Relevance
“…Important steps have been recently made towards the development of synthetic tools to allow the site-specific phosphorylation of native pLys and pArg peptides and mimetics of pHis in proteins 8 9 10 11 12 13 . These chemical tools have permitted the development of mass spectrometry (MS)-based methods or the generation of antibodies, leading to a better understanding of the biological role of these modifications 14 15 16 .…”
mentioning
confidence: 99%
“…Important steps have been recently made towards the development of synthetic tools to allow the site-specific phosphorylation of native pLys and pArg peptides and mimetics of pHis in proteins 8 9 10 11 12 13 . These chemical tools have permitted the development of mass spectrometry (MS)-based methods or the generation of antibodies, leading to a better understanding of the biological role of these modifications 14 15 16 .…”
mentioning
confidence: 99%
“…[3c, 5] Despite the challenging nature of the N—P bond, chemical biologists have recently begun to focus on the development of suitable tools for analyzing protein N-phosphorylation. [3d, 6] For example, Muir and colleagues recently reported the development of the first pan-phospho-histidine (pHis) specific antibody using a stable triazole-based pHis analog as the hapten. [6c] …”
mentioning
confidence: 99%
“…[3d, 6] For example, Muir and colleagues recently reported the development of the first pan-phospho-histidine (pHis) specific antibody using a stable triazole-based pHis analog as the hapten. [6c] …”
mentioning
confidence: 99%
“…[98] These methods, however,a re inherently limited by their lack of sequence specificity.I nt his regard, recently reported solidphase peptide synthetic methods to prepare pLys-or pArgcontaining peptides with defined site specificity should be invaluable for further studies on these PTMs and hydrolase enzymes. [113][114][115] For example, the pLys peptides synthesized by using this method were pivotal in the investigation of gasphase phosphoryl transfer during electron-transfer dissociation (ETD) tandemMS. [116] It has also been ac hallenge to accurately measuret he hydrolase enzymea ctivities.…”
Section: Chemical Toolsmentioning
confidence: 99%